In consequence, we can hypothesize that this could be an excellent starting point for investigations in additional cell lines to confirm our speculation that supposes a prognostic significance of KEAP1 in SCLC in clinical settings, and may also be related to NOTCH activity through DLL3 modulation. The gene discussed is DLL3; the disease is small cell lung carcinoma.